AI in AI in Diabetes Experts
The field of AI in diabetes is led by a diverse group of experts who are at the forefront of innovation. These professionals include researchers, data scientists, endocrinologists, and technologists who are dedicated to leveraging AI to address the complex challenges associated with diabetes management. Their expertise and collaborative efforts are instrumental in developing cutting-edge AI algorithms, predictive models, and decision support systems that optimize diabetes care.
Explore Solutions
Discover Dashboards Constructor™
Big Data Analytics Dashboard
Deep Pharma Intelligence has engineered an advanced analytical framework capable of defining, analysing, and predicting trends in the AI in Drug Development industry, and the DeepTech technologies powering it.
The Dashboard provides professional users with comparative analytical capabilities, including interactive, searchable and filterable databases of companies, investors and funding rounds, as well as Automated SWOT Analysis and AI-Driven Smart-Matching facilities.
Deep Pharma Intelligence – Powered by Deep Knowledge Group
Deep Pharma Intelligence is a subsidiary of Deep Knowledge Group, a data-driven consortium of commercial and non-profit organizations active on many fronts in the realm of DeepTech and Frontier Technologies (AI, Longevity, BioTech, Pharma, FinTech, GovTech, SpaceTech, FemTech, Data Science, InvestTech), ranging from scientific research to investment, entrepreneurship, analytics, consulting, media, philanthropy and more.